- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05539326
A Study of the Construct Validity of Community Walking Speed Data Collected Remotely With the Canary canturioTM te Tibial Extension
A Multicenter, Single- Arm Postmarket Study of the Construct Validity of Community Walking Speed Data Collected Remotely With the Canary canturioTM te Tibial Extension
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The primary endpoint is community walking speed, calculated as a mean, remotely captured over the 7 days prior to the patient's regularly scheduled office visit: specifically, the correlation (Pearson correlation coefficient) of community walking speed with the 4mWT.
The secondary endpoints are as follows:
- Correlation coefficient between community walking speed and the Timed Up and Go (TUG) Test
- Completeness of data collection and transmission by the study device
- Correlation coefficient between community walking speed and the Oxford Knee Score
- Correlation coefficient between community walking speed and the Knee Injury and Osteoarthritis Outcome Score Jr (KOOS JR)
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Colorado
-
Frisco, Colorado, United States, 80443
- Vail Summit Orthopaedics and Neurosurgery
-
-
Indiana
-
South Bend, Indiana, United States, 46635
- South Bend Orthopaedics
-
-
Mississippi
-
Jackson, Mississippi, United States, 39202
- Mississippi Sports Medicine and Orthopaedic Center
-
-
New Jersey
-
Sparta, New Jersey, United States, 07871
- Orthopedic NJ
-
-
Oregon
-
Oregon City, Oregon, United States, 97045
- Dr. Ballard
-
-
Texas
-
San Antonio, Texas, United States, 78209
- Orthopaedic Surgery and Sports Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patient must be 18 years of age or older at the time of surgery
- Patient is scheduled for or has undergone primary total knee arthroplasty using a Persona Personalized Knee System with Canary Tibial Extension (PIQ) TKA implant according to the appropriate surgical technique and IFU.
- Patient must be willing and able to complete the protocol required follow-up
- Patient has participated in the study-related informed consent process
- Patient has a platform-compatible personal computer located in their dwelling with substantially reliable wireless internet access and a USB port
Exclusion Criteria:
- Simultaneous bilateral TKA
- Staged bilateral TKA less than 6 months from indexed procedure
- Patient is a current alcohol or drug abuser
- Patient is known to be pregnant, breastfeeding, or considered a member of a protected class (e.g., prisoner, mentally incompetent, etc.)
- Patient has a psychiatric illness or cognitive deficit that will not allow proper informed consent and participation in follow-up program
- Patient has previous history of infection in the affected joint and/or a local or systemic infection that may affect the prosthetic joint
- Patient with mental or neurologic conditions who are unwilling or incapable of following postoperative care instructions
- Patient with Neuropathic Arthropathy
- Patient has rheumatoid arthritis accompanied by an ulcer of the skin or a history of recurrent breakdown of the skin
- Patient is undergoing procedures or treatments using ionizing radiation
- Patient has a known or suspected sensitivity to one or more of the implant materials.
- Patients with known orthopaedic lower extremity, spinal and/or neurologic conditions that could affect gait
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
PIQ Patients
Patient is scheduled for or has undergone primary total knee arthroplasty (TKA) using a Persona Personalized Knee System with Canary Tibial Extension (PIQ) TKA implant according to the appropriate surgical technique and IFU.
If you decide to take part in this research study, the general procedures include one follow-up visit where you will be asked to complete two performance-based tests that are used to assess your physical function following Total Knee Arthroplasty ("TKA").
As part of your standard of care, you will receive a Zimmer Persona® Personalized Knee System with Canary canturioTM (CTE) tibial extension.
As part of this study, subjects will be asked to perform two performance based tests called the 4 meter walk test and the timed up and go test.
Subjects will also be asked to complete a series of patient questionnaires that will assess their post-operative function.
|
Patients will be asked to perform a fast 4-meter walk test (4mWT) and the Timed up and Go (TUG) test in the clinic during their post-operative follow-up visit.
Both performance exams will be performed in a controlled environment within the physician's clinic.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
4 Meter Walk Test
Time Frame: 4 wks+2 weeks post TKA
|
A 4MWT test will be performed in the physician's clinic along a clear pathway of at least 8 in length in a designated area over solid flooring.
The 8-m distance will be measured with a starting (0m) and an end point (8m) with additional marks at 2m and 6m to identify the 4m which is the timed portion of the test.
A handheld, calibrated stopwatch will be used as the gold standard for measuring walking speed output during the 4 mWT, measuring the time it takes to complete the test.
|
4 wks+2 weeks post TKA
|
|
Timed Up and Go Test *(TUG)
Time Frame: 4 wks+2 weeks post TKA
|
Patients may use a walking aid if needed. Patients will begin by sitting back in a standard armchair. Investigator will identify a line 3 meters (9.8 feet) away on the floor. When the investigator says "go" the patient will:
|
4 wks+2 weeks post TKA
|
|
Community Walking Speed
Time Frame: 7 days prior to follow-up appoinment
|
Average walking speed
|
7 days prior to follow-up appoinment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Numeric Pain Rating Scale
Time Frame: wks+2 weeks post TKA
|
Patient Reported Outcome on level of Pain
|
wks+2 weeks post TKA
|
|
Oxford Knee Score
Time Frame: wks+2 weeks post TKA
|
Patient Reported Outcome on Clinical Function
|
wks+2 weeks post TKA
|
|
KOOS Jr
Time Frame: 4wks+2 weeks post TKA
|
Patient Reported Outcome on Clinical Function
|
4wks+2 weeks post TKA
|
|
Clinical Limping Evaluation
Time Frame: 4wks+2 weeks post TKA
|
Self Evaluation of Limping
|
4wks+2 weeks post TKA
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- POS-CTE-002P
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.